New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BOSTON--(BUSINESS WIRE)--Corvus Insurance, a leading provider of smart commercial insurance products powered by AI-driven risk data, today announced it has secured extensions to its recent Series C ...

Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and present ...

Corvus Pharmaceuticals (CRVS) stock falls after the company posted early-stage trial data for its lead asset, soquelitinib, ...

BOSTON--(BUSINESS WIRE)--Corvus Insurance, the leading provider of Smart Cyber Insurance ® products powered by AI-driven risk data, today released findings from its third Corvus Risk Insights Index™, ...

Corvus Robotics announced Corvus Trident, an AI-powered device that gives warehouses a continuous record of every pallet ...

Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive data and initiation of Phase 2 trial during the ...

The cyber insurance industry is likely to go mainstream and is a simple cost of doing business. Here are a few options to consider. Read now Corvus Insurance, a company focused on applying artificial ...